Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New French SGs (study groups) on implants, depression fillers:

This article was originally published in Clinica

Executive Summary

Two new study groups have been set up at the French healthcare product safety agency, AFSSAPS, the first on breast prostheses and the second on medical devices that fill skin depressions. The French authorities have long been concerned about safety of breast prostheses and have closely monitored these products, not hesitating to withdraw them from the market when there have been safety concerns.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066035

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel